Feb 15, 2021 | Webinar

Epigenetic marker for the monitoring of bladder tumours

Watch the presentation of Dr. Fernando Lozano Palacio
(Barcelona, Spain)

During the virtual VI Symposium Liquid Biopsy, organised from 25 till 27 January 2021 by a scientific committee from the University Hospital of Santiago (Spain), Dr. Fernando Lozano Palacio from the University Hospital Vall d’Hebron (Barcelona, Spain) gave an interesting presentation about biomarkers in bladder cancer, entitled “Epigenetic marker for the monitoring of bladder tumours”.

Watch this presentation to learn more about:

The current follow-up of Non Muscle-Invasive Bladder Cancer (NMIBC) with some considerations and pitfalls
The discomfort of regular cystoscopies
The role of urinary markers in the follow-up of NMIBC

Download the free slide resource and brochure

Download the brochure

All updates

Other updates

Urinary biomarkers for the surveillance of NMIBC

Nov 3, 2026 | Lecture

Can urinary biomarkers help address some of the key limitations of cystoscopy and urine cytology in the surveillance of non-muscle-invasive bladder cancer (NMIBC)? Watch this expert presentation to discover how urinary biomarkers may support a more patient-centred and...

Compare your opinion with peers and Prof. Joost Boormans

Feb 16, 2026 | Clinical case

Godelieve is a 77-year-old retired teacher. One year ago, she underwent TURBT of 1 small papillary tumour of 1 cm at the right bladder wall, which was detected during a cystoscopic examination for painless haematuria. The pathology report indicated pTa grade 2,...

Improving detection of high-grade recurrences missed by WLC using a urinary biomarker

Jan 16, 2026 | Publication

Improving detection of high-grade recurrences missed by WLC using a urinary biomarkerReviewed by Marek Babjuk Surveillance for non-muscle-invasive bladder cancer (NMIBC) relies on routine white-light cystoscopy (WLC) and urinary cytology as the diagnostic...